Through it, models are established that other assessment bodies can emulate. But the need for effectiveness analysis is great, particularly for technologies that have been widely adopted in community practice without the benefit of good data on efficacy. These efforts have the important goal of translating evidence into clinical practice. One important need is to improve the quality and quantity of data on the effects of health care technologies and interventions. The role of clinical trials is pivotal here.
Clinical trials are the gold standard for the development of efficacy data.
Funding for such trials for industry and the public sector must continue to be a priority. But this model is not being used widely in the industry. In conclusion, it is clear that technology assessment is a major contributor to improved quality and affordability of health care. It is vitally important to all stakeholders in the health care enterprise. Public and private cooperation are essential to further this important activity.